Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Leena Patel & Aswin Thaker. (2014) The effects of adenosine A2B receptor inhibition on VEGF and nitric oxide axis-mediated renal function in diabetic nephropathy. Renal Failure 36:6, pages 916-924.
Read now
Read now
Narisa Futrakul, Papada Chaisuriya, Kavi Ratanabanangkoon & Prasit Futrakul. (2013) Microvascular dysfunction in normotensive, normoalbuminuric, normo- or hyperfiltrate type 2 diabetes. Renal Failure 35:8, pages 1191-1192.
Read now
Read now
Narisa Futrakul & Prasit Futrakul. (2008) Renal Microvascular Disease in an Aging Population: A Reversible Process?. Renal Failure 30:4, pages 353-356.
Read now
Read now
Articles from other publishers (42)
S.P. Ramya Ranjan Nayak, Seenivasan Boopathi, B. Haridevamuthu & Jesu Arockiaraj. (2023) Toxic ties: Unraveling the complex relationship between endocrine disrupting chemicals and chronic kidney disease. Environmental Pollution 338, pages 122686.
Crossref
Crossref
Jaskiran Kaur, Kajal Kamboj, Ashok Kumar Yadav, Prabhjot Kaur, Vivek Kumar & Vivekanand Jha. (2022) Cholecalciferol supplementation and angiogenic markers in chronic kidney disease. PLOS ONE 17:6, pages e0268946.
Crossref
Crossref
Rosangela Lima de Freitas Galvão, Gdayllon Cavalcante Meneses, Marta Cristhiany Cunha Pinheiro, Alice Maria Costa Martins, Elizabeth De Francesco Daher & Fernando Schemelzer Moraes Bezerra. (2022) Kidney injury biomarkers and parasitic loads of Schistosoma mansoni in a highly endemic area in northeastern Brazil. Acta Tropica 228, pages 106311.
Crossref
Crossref
Thi Thuy Uyen Nguyen, Hyeongwan Kim, Yoon Jung Chae, Jong Hwan Jung & Won Kim. (2022) Serum VEGF-D level is correlated with renal dysfunction and proteinuria in patients with diabetic chronic kidney disease. Medicine 101:7, pages e28804.
Crossref
Crossref
Áine M. de Bhailís, Constantina Chrysochou & Philip A. Kalra. (2021) Inflammation and Oxidative Damage in Ischaemic Renal Disease. Antioxidants 10:6, pages 845.
Crossref
Crossref
Mei Li, Zoran Popovic, Chang Chu, Bernhard K. Krämer & Berthold Hocher. (2021) Endostatin in Renal and Cardiovascular Diseases. Kidney Diseases 7:6, pages 468-481.
Crossref
Crossref
Uwe Querfeld, Robert H. Mak & Axel Radlach Pries. (2020) Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity. Clinical Science 134:12, pages 1333-1356.
Crossref
Crossref
Erika Williams & Alejandro R. Chade. (2020) A Boolean Model of Microvascular Rarefaction to Predict Treatment Outcomes in Renal Disease. Scientific Reports 10:1.
Crossref
Crossref
Asmahan Eloueyk, Bilal Osta, Rashad Alameldinne & Dania Awad. (2019) Uremic Serum Induces Inflammation in Cultured Human Endothelial Cells and Triggers Vascular Repair Mechanisms. Inflammation 42:6, pages 2003-2010.
Crossref
Crossref
Pei, Juni, Harakalova, Duncker, Asselbergs, Koolwijk, Hinsbergh, Verhaar, Mokry & Cheng. (2019) Indoxyl Sulfate Stimulates Angiogenesis by Regulating Reactive Oxygen Species Production via CYP1B1. Toxins 11:8, pages 454.
Crossref
Crossref
Nkiruka V Arinze, Andrew Gregory, Jean M Francis, Alik Farber & Vipul C Chitalia. (2019) Unique aspects of peripheral artery disease in patients with chronic kidney disease. Vascular Medicine 24:3, pages 251-260.
Crossref
Crossref
Erika Guise, Jason E. Engel, Maxx L. Williams, Fakhri Mahdi, Gene L. BidwellIIIIII & Alejandro R. Chade. (2019) Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization. American Journal of Physiology-Renal Physiology 316:5, pages F1016-F1025.
Crossref
Crossref
Erika Guise & Alejandro R. Chade. (2018) VEGF therapy for the kidney: emerging strategies. American Journal of Physiology-Renal Physiology 315:4, pages F747-F751.
Crossref
Crossref
Linmin Chen, Binrui Yang, Benqin Tang, Guiyi Gong, Hiotong Kam, Cheng Gao, Yan Chen, Ruibing Wang & Simon Ming Yuen Lee. (2018) Differential angiogenic activities of naringin and naringenin in zebrafish in vivo and human umbilical vein endothelial cells in vitro. Journal of Functional Foods 49, pages 369-377.
Crossref
Crossref
Karsten Vanden Wyngaert, Amaryllis H. Van Craenenbroeck, Wim Van Biesen, Annemieke Dhondt, Anouk Tanghe, Ans Van Ginckel, Bert Celie & Patrick Calders. (2018) The effects of aerobic exercise on eGFR, blood pressure and VO2peak in patients with chronic kidney disease stages 3-4: A systematic review and meta-analysis. PLOS ONE 13:9, pages e0203662.
Crossref
Crossref
Antonietta Gigante, Luca Navarini, Domenico Margiotta, Antonio Amoroso, Biagio Barbano, Rosario Cianci, Antonella Afeltra & Edoardo Rosato. (2017) Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy. Microvascular Research 114, pages 41-45.
Crossref
Crossref
Toralph Ruge, Axel C Carlsson, Anders Larsson & Johan Ärnlöv. (2017) Endostatin: a promising biomarker in the cardiovascular continuum?. Biomarkers in Medicine 11:10, pages 905-916.
Crossref
Crossref
Natallia Shved, Gregor Warsow, Felix Eichinger, David Hoogewijs, Simone Brandt, Peter Wild, Matthias Kretzler, Clemens D. Cohen & Maja T. Lindenmeyer. (2017) Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts. Scientific Reports 7:1.
Crossref
Crossref
Isabel N. Schellinger, Nada Cordasic, Julian Panesar, Björn Buchholz, Johannes Jacobi, Andrea Hartner, Bernd Klanke, Joanna Jakubiczka-Smorag, Nicolai Burzlaff, Eva Heinze, Christina Warnecke, Uwe Raaz, Carsten Willam, Philip S. Tsao, Kai-Uwe Eckardt, Kerstin Amann & Karl F. Hilgers. (2017) Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease. Kidney International 91:3, pages 616-627.
Crossref
Crossref
A.C. Carlsson, C.J. Östgren, T. Länne, A. Larsson, F.H. Nystrom & J. Ärnlöv. (2016) The association between endostatin and kidney disease and mortality in patients with type 2 diabetes. Diabetes & Metabolism 42:5, pages 351-357.
Crossref
Crossref
Mehmet Kanbay, Baris Afsar, Dimitrie Siriopol, Hilmi Umut Unal, Murat Karaman, Mutlu Saglam, Mustafa Gezer, Ahmet Taş, Tayfun Eyileten, Ahmet Kerem Guler, İbrahim Aydin, Yusuf Oguz, Kayhan Tarim, Adrian Covic & Mahmut Ilker Yilmaz. (2016) Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival. European Journal of Internal Medicine 33, pages 81-87.
Crossref
Crossref
Yao-Jian Dong, Cheng Huang, De-Mou Luo, Jing-Guang Ye, Jun-Qing Yang, Guang Li, Jian-Fang Luo & Ying-Ling Zhou. (2015) Decrease of Glomerular Filtration Rate may be Attributed to the Microcirculation Damage in Renal Artery Stenosis. Chinese Medical Journal 128:6, pages 750-754.
Crossref
Crossref
Thor Ueland, Pål Aukrust, Ståle H. Nymo, John Kjekshus, John J.V. McMurray, John Wikstrand, Ursula-Henrike Wienhues-Thelen, Dirk Block, Christian Zaugg & Lars Gullestad. (2015) Predictive Value of Endostatin in Chronic Heart Failure Patients with Poor Kidney Function. Cardiology 130:1, pages 17-22.
Crossref
Crossref
Zhe-Rui Zhang, Jin-Hang Li, Shang Li, Ai-Lin Liu, Pui-Man Hoi, Hai-Yan Tian, Wen-Cai Ye, Simon Ming-Yuen Lee & Ren-Wang Jiang. (2014) In Vivo Angiogenesis Screening and Mechanism of Action of Novel Tanshinone Derivatives Produced by One-Pot Combinatorial Modification of Natural Tanshinone Mixture from Salvia Miltiorrhiza. PLoS ONE 9:7, pages e100416.
Crossref
Crossref
Shahram Eisa-Beygi, Marc Ekker, Thomas W. Moon, R. Loch Macdonald & Xiao-Yan Wen. (2014) Developmental processes regulated by the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway: Highlights from animal studies. Reproductive Toxicology 46, pages 115-120.
Crossref
Crossref
Toralph Ruge, Axel C. Carlsson, Tobias E. Larsson, Juan-JesPs Carrero, Anders Larsson, Lars Lind & Johan ÄrnlFv. (2014) Endostatin Level is Associated with Kidney Injury in the Elderly: Findings from Two Community-Based Cohorts. American Journal of Nephrology 40:5, pages 417-424.
Crossref
Crossref
Eduardo Reyna-Villasmil, Jorly Mejia-Montilla, Nadia Reyna-Villasmil, Duly Torres-Cepeda & Joel Santos-Bolívar. (2014) Endostatina sérica en preeclampsia y eclampsia. Diagnóstico Prenatal 25:1, pages 9-14.
Crossref
Crossref
Alejandro R. Chade. 2014. Renal Vascular Disease. Renal Vascular Disease
131
150
.
B Naumnik, E Koc-Żórawska & M Myśliwiec. (2013) Over-dialysis plasma RANTES increase depends on heparin dose and cardiovascular disease status. Advances in Medical Sciences 58:2, pages 311-319.
Crossref
Crossref
J. Yuan, Q. Guo, A. R. Qureshi, B. Anderstam, M. Eriksson, O. Heimburger, P. Barany, P. Stenvinkel & B. Lindholm. (2013) Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients. Nephrology Dialysis Transplantation 28:9, pages 2356-2363.
Crossref
Crossref
Tetsuhiro Tanaka & Masaomi Nangaku. (2013) Angiogenesis and hypoxia in the kidney. Nature Reviews Nephrology 9:4, pages 211-222.
Crossref
Crossref
Alejandro R. Chade. 2011. Comprehensive Physiology. Comprehensive Physiology
817
831
.
XI-QIANG DANG, XIAO-JIE HE, HAI-XIA CHEN, QING-NAN HE & ZHU-WEN YI. (2013) Number and function of peripheral blood endothelial progenitor cells in Henoch-Schönlein purpura nephritis children with different degrees of renal vascular lesions. Experimental and Therapeutic Medicine 5:3, pages 870-874.
Crossref
Crossref
Alejandro R. Chade & Nicholas Stewart. (2013) Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?. Journal of the American Society of Hypertension 7:2, pages 180-190.
Crossref
Crossref
Rukshana C. Shroff, Karen L. Price, Maria Kolatsi-Joannou, Alexandra F. Todd, David Wells, John Deanfield, Richard J. Johnson, Lesley Rees, Adrian S. Woolf & David A. Long. (2013) Circulating Angiopoietin-2 Is a Marker for Early Cardiovascular Disease in Children on Chronic Dialysis. PLoS ONE 8:2, pages e56273.
Crossref
Crossref
Jing Chen, L. Lee Hamm, Myra A. Kleinpeter, Fred Husserl, Islam Enver Khan, Chung-Shiuan Chen, Yanxi Liu, Katherine T. Mills, Chuan He, Nader Rifai, Eric E. Simon & Jiang He. (2012) Elevated Plasma Levels of Endostatin Are Associated with Chronic Kidney Disease. American Journal of Nephrology 35:4, pages 335-340.
Crossref
Crossref
Anna Stachurska, Magdalena Kozakowska, Alicja Jozkowicz, Jozef Dulak & Agnieszka Loboda. (2011) Aristolochic acid I and ochratoxin A differentially regulate VEGF expression in porcine kidney epithelial cells—The involvement of SP-1 and HIFs transcription factors. Toxicology Letters 204:2-3, pages 118-126.
Crossref
Crossref
Alejandro R. Chade. (2011) Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 300:4, pages R783-R790.
Crossref
Crossref
Shraddha V. Bhadada, Bhoomika R. Goyal & Mayur M. Patel. (2011) Angiogenic targets for potential disorders. Fundamental & Clinical Pharmacology 25:1, pages 29-47.
Crossref
Crossref
Jinye Song, Liqiang Meng, Shen Li, Lei Qu & Xiaomei Li. (2009) A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Vascular Pharmacology 50:5-6, pages 185-193.
Crossref
Crossref
A Rydzewska-Rosolowska, J Borawski & M Mysliwiec. (2009) High plasma endostatin level unaffected by low-molecular weight heparin in hemodialysis patients - a preliminary report. Advances in Medical Sciences 54:2.
Crossref
Crossref
. (2009) Current World Literature. Current Opinion in Nephrology & Hypertension 18:1, pages 91-97.
Crossref
Crossref